Liang Song
Chief Executive Officer at Insight Lifetech Co., Ltd.
Profile
Liang Song is the founder of Insight Lifetech Co., Ltd., a company founded in 2015.
He currently holds the titles of Chairman, CEO & General Manager at Insight Lifetech Co., Ltd.
Prior to founding Insight Lifetech Co., Ltd., Dr. Song worked as the Director-Laboratory for Biomedical Optics at The Shenzhen Institutes of Advanced Technology from 2012 to 2016.
Dr. Song obtained a doctorate degree from Washington University in St. Louis in 2010.
He also holds an undergraduate degree from Wuhan University, which he received in 2003, and a graduate degree from The Chinese University of Hong Kong, which he obtained in 2006.
Liang Song active positions
| Companies | Position | Start |
|---|---|---|
Insight Lifetech Co., Ltd.
 Insight Lifetech Co., Ltd. Medical SpecialtiesHealth Technology Insight Lifetech Co., Ltd. engages in the manufacture and sale of interventional cardiovascular diagnostic and therapy products. It offers exchange fractional flow reserve (FFR) microcatheters, cardiovascular pressure measurement (CPM) systems, intravascular ultrasound systems, and microcatheters for complex percutaneous coronary intervention (PCI). The company was founded by Xiao Yang Fu and Li Li Chen on December 11, 2015 and is headquartered in Shenzhen, China. | Chief Executive Officer | 10/12/2015 |
Former positions of Liang Song
| Companies | Position | End |
|---|---|---|
| The Shenzhen Institutes of Advanced Technology | Corporate Officer/Principal | 29/02/2016 |
Training of Liang Song
| Washington University in St. Louis | Doctorate Degree |
| Wuhan University | Undergraduate Degree |
| The Chinese University of Hong Kong | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Insight Lifetech Co., Ltd.
Insight Lifetech Co., Ltd. Medical SpecialtiesHealth Technology Insight Lifetech Co., Ltd. engages in the manufacture and sale of interventional cardiovascular diagnostic and therapy products. It offers exchange fractional flow reserve (FFR) microcatheters, cardiovascular pressure measurement (CPM) systems, intravascular ultrasound systems, and microcatheters for complex percutaneous coronary intervention (PCI). The company was founded by Xiao Yang Fu and Li Li Chen on December 11, 2015 and is headquartered in Shenzhen, China. | Health Technology |
- Stock Market
- Insiders
- Liang Song
